Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Solaf Kafnar"'
Autor:
Infran Maghfoor, Eshrak Al Shaibani, Ioannis Apostolidis, Mohamad Darweesh, Harbi Salman, Enas Mutahar, Khalid Al Anezi, M S Rauf, Panayotis Kaloyannidis, Jenifer Bacal, Hani Al Hashmi, Tusneem Elhassan, Solaf Kafnar, Saad Akhtar
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S187-S188
Background The ideal conditioning regimen still remains a challenge in the autologous stem cell transplantation (ASCT) setting for relapsed/refractory Hodgkin Lymphoma (RR-HL). BEAM is the most popular preparative regimen but single agent high dose M
Autor:
Eshrak Al Shaibani, Mohamad Darweesh, Ioannis Apostolidis, Enas Mutahar, Ahmed Buali, Solaf Kafnar, Eman Debawy, Rawan Omari, Khalid Al Anezi, Panayotis Kaloyannidis, Jenifer Bacal, Reem Khalili, Hani Al Hashmi
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S397-S398
Introduction Patients with Hodgkin (HL) or Non-Hodgkin Lymphoma (NHL) who have either bulky masses at relapse or residual disease post salvage therapy, have poor outcome even after autologous stem cell transplantation (ASCT). Involved field radiother
Autor:
Solaf Kafnar, Khalid Al Anezi, Eshrak Al Shaibani, Panayotis Kaloyannidis, Hani Al Hashmi, Jenifer Bacal, Nihad Mokhtar, Mohammed Darweesh, Manar Abdulbaki, John Apostolidis, Salman Al Harbi
Publikováno v:
Biology of Blood and Marrow Transplantation
Autor:
Hani Al Hashmi, Reem Khalili, Eshrak Al Shaibani, Mohamad Darweesh, Khalid Al Anezi, Solaf Kafnar, Panayotis Kaloyannidis, Ayed Garni, Jenifer Bacal, Ioannis Apostolidis, Enas Mutahar
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S393
Background Disease chemosensitivity to salvage treatment is a major predictive factor for a favorable outcome after autologous stem cell transplantation (ASCT) for patients with refractory lymphomas. Therefore the importance of effective and safe sal